Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 6;13(6):482.
doi: 10.3390/pathogens13060482.

Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: "Digging Their Graves with Their Forks"

Affiliations

Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: "Digging Their Graves with Their Forks"

Ange W Embo-Ibouanga et al. Pathogens. .

Erratum in

Abstract

The expansion of drug resistant parasites sheds a serious concern on several neglected parasitic diseases. Our recent results on cancer led us to envision the use of peptide-alkoxyamines as a highly selective and efficient new drug against schistosome adult worms, the etiological agents of schistosomiasis. Indeed, the peptide tag of the hybrid compounds can be hydrolyzed by worm's digestive enzymes to afford a highly labile alkoxyamine which homolyzes spontaneously and instantaneously into radicals-which are then used as a drug against Schistosome adult parasites. This approach is nicely summarized as digging their graves with their forks. Several hybrid peptide-alkoxyamines were prepared and clearly showed an activity: two of the tested compounds kill 50% of the parasites in two hours at a concentration of 100 µg/mL. Importantly, the peptide and alkoxyamine fragments that are unable to generate alkyl radicals display no activity. This strong evidence validates the proposed mechanism: a specific activation of the prodrugs by the parasite proteases leading to parasite death through in situ alkyl radical generation.

Keywords: alkoxyamines; new concept; prodrug; schistosoma.

PubMed Disclaimer

Conflict of interest statement

Jerome Boissier is the cofounder of ParaDev company that was subcontracted to carry out the antiparasitic tests on the Schistosome.

Figures

Scheme 1
Scheme 1
Scheme for the concept: digging their graves with their forks.
Figure 1
Figure 1
Peptide-alkoxyamines investigated as anti-schistosomal drugs. L and D are for the configuration of the residues on the peptides as given by Fischer’s rules.
Scheme 2
Scheme 2
Dynamic Covalent Bond in alkoxyamines: kd for the homolysis rate constant and kc for the re-formation reaction.
Scheme 3
Scheme 3
Preparation of alkoxyamines A3LA7L: (a) ClCOOEt, Et3N, 4-vinylaniline, DCM, 0 °C to −15 °C to rt, overnight, 90%; (b) salen, MnCl2, TEMPO, O2 (air), THF, rt, overnight, 54%; (c) CF3COOH, DCM, rt, 2 h, 81%; (d) DIPEA, HOBT, Boc-L-Phe-L-Val-OH P5L, DCC, DCM, 0 °C to rt, overnight, 74%; (e) CF3COOH, DCM, rt, 4 h, 60%; (f) NaOH 1 M, DCM, 86%; (g) DIPEA, HOBT, HO-Suc-OBn, EDC.HCl, DCM, 0 °C to rt, overnight, 73%; (h) H2/Pd(C), DCM/MeOH (v:v 1:1), rt, 3 h, 90%.
Scheme 4
Scheme 4
Preparation of the peptide tag: (a) DIPEA, HOBT, DCC, DCM, 0 °C to rt, overnight, 97%; (b) H2/Pd(C), DCM/MeOH (v/v 1:1), rt, 3 h, 94%; (c) DIPEA, HOBT, HCl.NH2-L-Phe-OBn, DCC, DCM, 0 °C to rt, overnight, 73%; (d) CF3COOH, DCM, rt, 4 h, 79%; (e) DIPEA, HOBT, HO-Suc-OBn, EDC.HCl, DCM, 0 °C to rt, overnight, 62%; (f) H2/Pd(C), MeOH, rt, 3 h, 94%; (g) HOBT, HO-Suc-OBn, EDC.HCl, DCM, 0 °C to rt, overnight, 47%.
Scheme 5
Scheme 5
Preparation of the peptide tag H2N-L-Phe-L-Val-L-Phe-OH P18L: (a) DIPEA, HOBT, DCC, DCM, 0 °C to rt, overnight, 86%; (b) H2/Pd(C), DCM, rt, 4 h, 98%; (c) DIPEA, HOBT, HCl.NH2-L-Phe-OBn, DCC, DCM, 0 °C to rt, overnight, 71%; (d) DBU, DCM, rt, 4 h, 57%; (e) H2/Pd(C), DCM/MeOH (v:v 1:1), rt, 3 h, 52%.
Scheme 6
Scheme 6
Preparation of models. (a) ClCOOEt, Et3N, 4-ethylaniline, DCM, 0 °C to −15 °C to rt, overnight, 88%; (b) CF3COOH, DCM, rt, 1 h, quantitative for P20L and 60% for P22L; (c) DIPEA, HOBT, Boc-L-Phe-L-Val-OH, DCC, DCM, 0 °C to rt, overnight, 93%; (d) NaOH 1 M, DCM, 92%; (e) HOBT, HO-Suc-OBn, EDC.HCl, DCM, 0 °C to rt, overnight, 50%; (f) H2/Pd(C), DCM/MeOH (v:v 1:1), rt, overnight, 96%.
Scheme 7
Scheme 7
Enzymatic activity affording potentially toxic peptides (a) and molecules mimicking alkoxyamines (b).
Scheme 8
Scheme 8
Scheme for the activation of alkoxyamine A5L by enzyme.

References

    1. Mouahid J., Moneé G. Schistosoma spp. In: Rose J.B., Jimeénez-Cisneros B., Robertson L., editors. Water and Sanitation for the 21st Century: Health and Microbiological Aspects of Excreta and Wastewater Management (Global Water Pathogen Project) Michigan State University; East Lansing, MI, USA: UNESCO; Paris, France: 2019. Part 3: Specific Excreted Pathogens: Environmental and Epidemiology Aspects—Section 4:, Helminths.
    1. Theétiot-Laurent S.A.-L., Boissier J., Robert A., Meunier B. A Schistosomiasis Model with Diffusion Effects. Angew. Chem. Int. Ed. 2013;52:7936–7956. - PubMed
    1. Summers S., Bhattacharyya T., Allan F., Stothard J.R., Edielu A., Webster B.L., Miles M.A., Bustinduy L.A. A review of the genetic determinants of praziquantel resistance in Schistosoma mansoni: Is praziquantel and intestinal schistosomiasis a perfect match? Front. Trop. Dis. 2022;3:933097. doi: 10.3389/fitd.2022.933097. - DOI
    1. Skelly P.J., Da’dara A.A., Li X.-H., Castro-Borges W., Alan Wilson R. Schistosome feeding and regurgitation. PLoS Pathog. 2014;10:e1004246. doi: 10.1371/journal.ppat.1004246. - DOI - PMC - PubMed
    1. Egan T.J. Haemozoin formation. Mol. Biochem. Parasitol. 2008;157:127–136. doi: 10.1016/j.molbiopara.2007.11.005. - DOI - PubMed

LinkOut - more resources